Furthermore, Gemin4 is known to be regulated by the AR and associates with prostate cancer progression [4, 26], which is highly relevant in the context of prostate cancer and CaMKK2 biology as the AR is also a major driver of CaMKK2 expression, disease progression and biology [2]. This evidence concerns the gene CAMKK2 and prostate carcinoma.